Protocol · Neurological Health
Fragile X Syndrome Supportive Care Protocol
Omega-3 Fatty Acids and Vitamin D are the core of this stack, with 7 supporting supplements. Each row gives the amount the protocol lists and the grade our evidence database holds for that supplement in Fragile X Syndrome Supportive Care.
We are re-verifying the studies cited on protocol pages; only confirmed citations are shown.
The stack
9 supplements · none graded yet
| Grade | Supplement | Amount listed | Why it’s in the stack | Evidence on file |
|---|---|---|---|---|
| Primary stackThe core of this protocol | ||||
| Omega-3 Fatty Acids | Amount listed: 1–2 g EPA+DHA daily (adjust for age/weight in children) | Supports brain development and function; may help with behavioral symptoms | Not graded yet | |
| Vitamin D | Amount listed: 1,000–2,000 IU daily (children); 2,000–4,000 IU daily (adults) | Supports brain development and function; deficiency common in developmental disorders | Not graded yet | |
| Supporting stackListed as additions to the core | ||||
| Melatonin | Amount listed: 0.5–5 mg 30–60 minutes before bedtime (start low) | Helps with sleep disturbances common in Fragile X; regulated melatonin production impaired | Not graded yet | |
| Magnesium | Amount listed: 3–6 mg/kg/day in children; 300–400 mg daily in adults | Supports nervous system function; may help with hyperactivity and sleep | Not graded yet | |
| Probiotics | Amount listed: 10–20 billion CFU daily (multi-strain) | Gut-brain axis support; GI issues common in Fragile X | Not graded yet | |
| Vitamin B6 | Amount listed: 50–100 mg daily (adults); weight-adjusted for children | Cofactor for neurotransmitter synthesis; studied in developmental disorders | Not graded yet | |
| L-Carnitine | Amount listed: 30–50 mg/kg/day in divided doses | Supports mitochondrial function; may help with cognitive symptoms
| Not graded yet | |
| Zinc | Amount listed: 10–15 mg daily for children; 15–30 mg daily for adults | Supports immune function and brain development | Not graded yet | |
| Folinic Acid | Amount listed: 0.4–2 mg/kg/day (under medical supervision) | Active form of folate that crosses blood-brain barrier; studied in autism | Not graded yet | |
How this protocol works
In plain language
Fragile X syndrome (FXS) is the most common inherited cause of intellectual disability and autism spectrum disorder. It's caused by a mutation in the FMR1 gene on the X chromosome that prevents production of FMRP protein, essential for normal brain development. Boys are typically more severely affected than girls (who have a backup X chromosome). Features include intellectual disability (ranging from mild to severe), autism-like behaviors, anxiety, ADHD, sensory sensitivities, seizures (in some), and distinctive physical features (long face, large ears, flexible joints).
CRITICAL: Fragile X syndrome requires comprehensive medical care from specialists experienced with the condition (developmental pediatricians, neurologists, geneticists). While there's no cure, early intervention services (speech therapy, occupational therapy, behavioral therapy, special education) significantly improve outcomes. Medications may help manage symptoms like anxiety, ADHD, aggression, and seizures. Research into targeted treatments is ongoing. These supplements may support overall health and development but cannot treat the underlying genetic condition. Always coordinate with the medical team.
Omega-3 Fatty Acids* support brain function and have been studied in various neurodevelopmental disorders. They may help with behavioral symptoms.
Vitamin D* supports brain development, and deficiency is common in developmental disorders.
Melatonin* helps with sleep problems, which are very common in Fragile X and significantly impact quality of life.
Magnesium* supports nervous system function and may help with hyperactivity.
Probiotics* support the gut-brain axis. GI issues are common in Fragile X.
Vitamin B6* is a cofactor for neurotransmitter synthesis.
L-Carnitine* has been studied specifically in Fragile X with some positive results for hyperactive behavior.
Zinc* supports brain development and immune function.
Folinic Acid* crosses the blood-brain barrier and has been studied in autism.
Expected timeline: Benefits from supplements, if any, would be expected over months of consistent use. Progress depends on comprehensive early intervention and therapy.